Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Thomas Marron is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
Duttagupta, S., Messaoudene, M., Hunter, S., Desilets, A., Jamal, R., Mihalcioiu, C., Belkaid, W., Marcoux, N., Fidelle, M., Suissa, D., Ponce, M., Geiger, M., Malo, J., Piccinno, G., Punčochář, M., Filin, A., Heidrich, V., Rusu, D., Mbaye, B. & Durand, S. & 29 others, , 2026, (Accepted/In press) In: Nature Medicine.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Global advances and future directions in lung cancer care: expert consensus and strategic priorities
Meyer, M. L., Peters, S., Jänne, P. A., Mok, T. S., Bunn, P. A., Abdel Karim, N., Altorki, N. K., Arrieta, O., Bar, J., Cappuzzo, F., Carbone, D., Dacic, S., Diehn, M., Dziadziuszko, R., Felip, E., Flores, R., Florez, N., Forde, P. M., Gainor, J. F. & Gray, J. E. & 39 others, , Feb 2026, In: ESMO Open. 11, 2, 106034.Research output: Contribution to journal › Review article › peer-review
Open Access -
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
Gonzalez-Kozlova, E., Sweeney, R., Figueiredo, I., Tuballes, K., Ozbey, S., Hamon, P., Park, M. D., Ioannou, G., Nose, Y., Guo, R., Restrepo, P., Buckup, M., Roudko, V., Hennequin, C., Le Berichel, J., Venturini, N., Halasz, L., Troncoso, L., Tabachnikova, A. & Chang, C. & 42 others, , 2026, (Accepted/In press) In: Nature Medicine.Research output: Contribution to journal › Article › peer-review
Open Access -
Morbidity and Mortality Outcomes of Dupilumab for Cutaneous Immune-Related Adverse Events
Block, B. R., Mehta, J., Owji, S., Feng, D., Marron, T. U. & Gulati, N., 2026, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
Stefanini, B., Fulgenzi, C. A. M., Scheiner, B., Korolewicz, J., Cheon, J., Nishida, N., Ang, C., Marron, T. U., Wu, Y. L., Saeed, A., Wietharn, B., Rimassa, L., Pirozzi, A., Cammarota, A., Pressiani, T., Pinter, M., Balcar, L., Huang, Y. H., Mehan, A. & Phen, S. & 23 others, , 2025, In: Journal of Hepatocellular Carcinoma. 12, p. 671-683 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations
Press/Media
-
Chrysea Announces Collaboration With Mount Sinai To Study Sprevive® Dose Levels In Humans
Merad, M., DePalo, L. R. & Marron, T.
12/01/26 → 28/01/26
44 items of Media coverage
Press/Media
-
Mount Sinai Study Finds Antibody-Producing Immune Cells Can Help Shape Cancer Immunotherapy
Sweeney, R., Merad, M., Kim-Schulze, S., Marron, T. & Gnjatic, S.
27/01/26 → 28/01/26
8 items of Media coverage
Press/Media
-
Overnight News Digest: Trump links Nobel snub to trade war
20/01/26
1 item of Media coverage
Press/Media
-
Can exercise and anti-inflammatories fend off aging? A study aims to find out
Merad, M. & Marron, T.
19/01/26
101 items of Media coverage
Press/Media
-
New Liver Cancer Study Findings Recently Were Reported by Researchers at Icahn School of Medicine at Mount Sinai (Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy)
Lindblad, K., Merad, M., Marron, T., Faith, J. & Gnjatic, S.
14/01/26
1 item of Media coverage
Press/Media